Edogawa-ku, Japan

Shigeru Ichikawa


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shigeru Ichikawa: A Focus on 2-Azetidinone Derivative Production

Introduction: Shigeru Ichikawa is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative methods for producing chemical compounds. His work exemplifies the intersection of invention and science, particularly in the synthesis of optically active substances.

Latest Patents: Shigeru Ichikawa holds a patent for a method of producing a 2-azetidinone derivative. This patent describes a process where a specific compound undergoes treatment with an enzyme that can asymmetrically hydrolyze an ester. The result is the formation of a novel compound represented by a defined chemical formula. This method is notable for its efficiency, allowing the production of optically active 2-azetidinone derivatives in significant quantities and at a low cost.

Career Highlights: Ichikawa is associated with Daiichi Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry. His role in the company contributes to advancements in drug development and synthesis, demonstrating his commitment to pushing the boundaries of pharmaceutical innovations.

Collaborations: Throughout his career, Shigeru Ichikawa has worked alongside talented colleagues, including Kouji Sato and Tsutomu Yagi. These collaborations emphasize the importance of teamwork in driving forward the innovative processes and ideas within the pharmaceutical sector.

Conclusion: Shigeru Ichikawa’s contributions to the field of pharmaceuticals, particularly through his patented method for producing 2-azetidinone derivatives, highlight the impactful role of inventors in advancing scientific knowledge and practical applications. His work not only benefits his company but also contributes to the broader field of pharmaceutical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…